STRATA CRITICAL MEDICAL, INC. (SRTA)

5.32USD -0.93% (-0.05)

Over 6M: +16.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

4 5 6
Mar Apr May Jun Jul Aug Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Income: -5.6M Q3 '25 — Net Income: 57.4M Q4 '25 — Operating Income: -6.4M Q4 '25 — Net Income: -8.8M Q1 '26 — Operating Income: -3M Q1 '26 — Net Income: 2.2M Q2 '26 — Operating Income: -5.4M Q2 '26 — Net Income: -10.5M 0 15M 30M 45M 60M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Income Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.1
OE margin -25.6%
Oper. margin -8.0%
ROIC -6.3%
ROA 12.1%
ROE 14.4%
Accruals 22.9%
FCF margin -18.9%
Gross margin 16.1%
OCF margin -14.1%
ROCE -7.1%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 1.8×
EV/OE -6.9×
P/B 1.7×
P/E 11.8×
EV/GP 10.9×
P/C 20.8×
FCF yield -10.2%
Div. yield —
EV/EBIT —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.4
RPO / sales 0.036×
Segment HHI 0.91 HHI
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.0
ND/EBITDA 0.051
Cash runway 0.47 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 2.6×
F-score 4.5 pts
Cash / Debt —
Interest cover —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.5
Sales/sh Y/Y +57.4%
Sales CAGR 4Y +37.7%
Sales Q/Q +60.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.